Ophthotech Corp (NASDAQ:OPHT)

2.78
Delayed Data
As of May 23
 -0.035 / -1.25%
Today’s Change
2.24
Today|||52-Week Range
3.60
-11.06%
Year-to-Date

Today’s Trading

Previous close2.81
Today’s open2.81
Day’s range2.77 - 2.84
Volume57,821
Average volume (3 months)233,065
Market cap$97.9M
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-150.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+312.46%
P/E ratio0.7
Price/Sales0.54
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.05-0.67%
BLRXBioLine RX Ltd+0.02+1.82%
GLMDGalmed Pharmaceutica...-0.04-0.58%
RGLSRegulus Therapeutics...+0.02+2.83%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$210.0M
Annual profit (last year)$114.2M
Net profit margin54.39%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Glenn P. Sblendorio
Chief Operating Officer &
Senior Vice President
Keith Westby
Corporate headquarters
New York, New York

Forecasts